Clarins Beauty Enhancing Products

If you have purchased any of Clarins’ “Beauty-Enhancing Products” listed below, you may have suffered financially. You have likely paid more for these products because of Clarins’ unsubstantiated claims that these creams, lotions, and serums have certain age-negating effects or reduce and reverse the appearance of cellulite. You may have legal claims against Clarins and should contact an attorney to discuss your rights.

Clarins Beauty Enhancing Products

A class action lawsuit against Clarins USA, Inc., Clarins Inc., Clarins North America, Inc., Clarins Group North America, Inc., Clarins SA, and Clarins Paris (collectively, “Clarins”) was filed on April 8, 2014 in federal court in Florida.

If you purchased a Clarins’ Beauty-Enhancing Product and did not see the promised results, it is not too late to get involved.

What is the Clarins Beauty Enhancing Products Lawsuit About?

Clarins touts itself as “No. 1 in European luxury skin care” on its website (www.clarinsusa.com) and in its advertising and marketing materials. It sells numerous skincare products—creams, lotions, and serums—that it claims to have anti-aging or age-reversing benefits such as fewer wrinkles and the reduction of cellulite.

The lawsuit claims that Clarins’ marketing pitch for these supposed anti-aging and anti-cellulite products is the same as that of the classic snake-oil salesman, allegedly duping consumers with false promises of anti-aging results that it cannot deliver. The Company promotes these “Fountain of Youth” products with one alleged goal: profit for Clarins.

Affected Clarins Product Lines

Clarins Beauty-Enhancing Products are currently found on the company website in the following “collections:”

  • Body Lift
  • Extra-Firming
  • HydraQuench
  • Multi-Active
  • Shaping Facial Lift
  • Super Restorative
  • UV Plus HP
  • Vital Light

This list is not exhaustive. Other Clarins collections and discontinued products or product lines may also be considered Beauty-Enhancing Products for purposes of claims against Clarins.

Our attorneys are interested in talking to you if you bought and used any Clarins product and did not see the promised results.

Clarins touts itself as “No. 1 in European luxury skin care” on its website and in its advertising and marketing materials.

Clarins markets its products largely directly through the Internet and in print, and through trained salespeople in department stores.

Clarins’ Internet marketing includes, for example, video presentations, statistical data, ingredient benefits, how-to videos and question and answer information on its own website (clarinsusa.com). In addition, Clarins’ products and advertisements appear on numerous third-party retailer websites such as Sephora.com, Macys.com, Amazon.com, Neimanmarcus.com, Nordstrom.com, and Facebook.com, to name a few. Many of its commercials and promotional videos are also readily accessible on youtube.com. Clarins also heavily markets its Beauty-Enhancing Products in print media, including advertisements in such widely-circulated magazines as Glamour, Elle, Marie Claire, Vogue and Allure, among others.

While lower-priced consumer products are available on the shelves of drug stores and supermarkets, the Beauty-Enhancing Products are sold mainly though counters at high-end department stores. Salespersons who are trained by Clarins to sell its Beauty-Enhancing Products routinely occupy the counters, where Clarins also provides consumers access to product displays and sales brochures.

Want to know if you have legal options regarding this Clarins Beauty Enhancing Products lawsuit?

If you have purchased any Clarins Beauty-Enhancing Product (discussed in more detail above) please contact Grant & Eisenhofer P.A. to discuss your potential claim by submitting the form, or by calling us at 888-554-3529.

Please visit Grant & Eisenhofer to learn more about us and our expert consumer claims practice.

  • Tyco - $2.9B
  • DaimlerChrysler - $300M
  • Royal Dutch/Shell Transport - $450M
  • Abbott Labs - $1.6B
  • GlaxoSmithKline - $1.04B
  • Genetically Modified Rice - $920M